Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5901
FT Vest US Equity Buffer ETF August
FAUG
$1.43B
| $161K | ﹤0.01% |
2,850
| – | – |
2021 Q1
21 quarters
|
|
5902
Eastern Company
EML
$146M
| $161K | ﹤0.01% |
5,770
-903
| -14% | -$19.8K |
2013 Q2
52 quarters
|
|
5903
Five Point Holdings
FPH
$307M
| $160K | ﹤0.01% |
30,404
-4,290
| -12% | -$21.5K |
2017 Q2
36 quarters
|
|
5904
Pharming Group
PHAR
$682M
| $160K | ﹤0.01% |
11,500
+11
| +0.1% | +$159 |
2021 Q1
21 quarters
|
|
5905
Innovator US Equity Buffer ETF January
BJAN
$349M
| $160K | ﹤0.01% |
2,713
| – | – |
2020 Q3
23 quarters
|
|
5906
Dimensional US Large Cap Vector ETF
DFVX
$552M
| $159K | ﹤0.01% |
1,933
+1,819
| +1,596% | +$146K |
2024 Q2
8 quarters
|
|
5907
Duluth Holdings
DLTH
$151M
| $159K | ﹤0.01% |
35,433
+2,050
| +6% | +$7.4K |
2015 Q4
42 quarters
|
|
5908
Asure Software
ASUR
$207M
| $158K | ﹤0.01% |
19,958
-33,560
| -63% | -$292K |
2013 Q4
50 quarters
|
|
5909
Innovator Deepwater Frontier Tech ETF
LOUP
$209M
| $158K | ﹤0.01% |
1,607
+1,228
| +324% | +$106K |
2021 Q1
21 quarters
|
|
5910
FT Vest US Equity Moderate Buffer ETF July
GJUL
$413M
| $158K | ﹤0.01% |
3,639
| – | – |
2024 Q4
6 quarters
|
|
5911
WisdomTree European Opportunities Fund
OPPE
$287M
| $158K | ﹤0.01% |
2,834
+1
| +0% | +$57 |
2015 Q1
45 quarters
|
|
5912
First Trust Asia Pacific ex-Japan AlphaDEX Fund
FPA
$114M
| $158K | ﹤0.01% |
2,954
+1,066
| +56% | +$55.1K |
2013 Q2
52 quarters
|
|
5913
Eikon Therapeutics
EIKN
$380M
| $157K | ﹤0.01% |
12,032
-3,241
| -21% | -$33.1K |
2026 Q1
1 quarter
|
|
5914
Clarus
CLAR
$132M
| $157K | ﹤0.01% |
49,822
-50,406
| -50% | -$145K |
2013 Q2
52 quarters
|
|
5915
Endava
DAVA
$101M
| $157K | ﹤0.01% |
55,421
+1,973
| +4% | +$7.28K |
2018 Q3
31 quarters
|
|
|
MAMK
5916
DELISTED
MaxsMaking Inc
MAMK
| $157K | ﹤0.01% |
12,051
| – | – |
2025 Q4
2 quarters
|
|
5917
AB International Low Volatility Equity ETF
ILOW
$1.8B
| $154K | ﹤0.01% |
3,396
| – | – |
2025 Q2
4 quarters
|
|
5918
Janus Henderson Small Cap Growth Alpha ETF
JSML
$348M
| $154K | ﹤0.01% |
1,659
| – | – |
2022 Q1
17 quarters
|
|
5919
Xerox Holdings Corp Warrants
XRXDW
$16.7M
| $154K | ﹤0.01% |
561,318
-305,846
| -35% | -$83.3K |
2026 Q1
1 quarter
|
|
5920
Vanguard ESG US Corporate Bond ETF
VCEB
$1.2B
| $154K | ﹤0.01% |
2,458
+1,514
| +160% | +$95.1K |
2024 Q1
9 quarters
|
|
5921
T. Rowe Price Floating Rate ETF
TFLR
$863M
| $154K | ﹤0.01% |
3,060
+1
| +0% | +$51 |
2025 Q1
5 quarters
|
|
5922
Ovid Therapeutics
OVID
$428M
| $153K | ﹤0.01% |
56,919
+7,364
| +15% | +$19K |
2017 Q2
36 quarters
|
|
5923
Comstock Holding Companies
CHCI
$180M
| $153K | ﹤0.01% |
9,571
-10
| -0.1% | -$166 |
2022 Q1
17 quarters
|
|
5924
Invesco RAFI Strategic US ETF
IUS
$988M
| $150K | ﹤0.01% |
2,288
+1,465
| +178% | +$93K |
2023 Q4
10 quarters
|
|
5925
Seneca Foods Class B
SENEB
$1.25B
| $150K | ﹤0.01% |
863
| – | – |
2013 Q4
50 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.